ArticleCancer cell2015

T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.

Ingunn M Stromnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.